The truth about hormone replacement therapy and breast cancer

By Priyadarshi Sewanti   Fernandez Imelyn M   Voige Hayley   Del Priore Giuseppe  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 1, 2007-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

OBSERVATIONS AND ADVERTISING: CONTROVERSIES IN THE PRESCRIBING OF HORMONE REPLACEMENT THERAPY

By Katz Anne  

Health Care For Women International, Vol. 24, Iss. 10, 2003-12 ,pp. : 927-939

Routledge Ltd

Access to resources Recommend Favorite

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment

By Conner P.   Christow A.   Kersemaekers W.   Söderqvist G.   Skoog L.   Carlström K.   Tani E.   Mol-Arts M.   Schoultz B. von  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women

By de Lignières B.   de Vathaire F.   Fournier S.   Urbinelli R.   Allaert F.   Le M. G.   Kuttenn F.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 332-340

Informa Healthcare

Access to resources Recommend Favorite

Health risks after cessation of postmenopausal hormone therapy

By Pines Amos   Sturdee David   Birkhauser Martin  

Climacteric, Vol. 11, Iss. 3, 2008-01 ,pp. : 179-180

Informa Healthcare

Access to resources Recommend Favorite